Showing pharmacokinetics for Daidzein metabolite after consumption of Daidzein in humans

Rufer C.E., Bub A., Moseneder J., Winterhalter P., Sturtz M., Kulling S.E. (2008) Pharmacokinetics of the soybean isoflavone daidzein in its aglycone and glucoside form: a randomized, double-blind, crossover study. Am J Clin Nutr 87:1314-23 pubmed (18469255)

Plasma and Urine analysed after enzymatic deconjugation Help

Show related sources from the same publication
Plasma Concentration (µmol/L)
Number Dose Multiple Dose Duration Time (hours) Polyphenol Source
Name as described in publication
0 1 3 6 12 24
1 1 capsule Single Dose 0 0 0.2 0.4 0.35 0
daidzein capsule
L)&chxp=1,50|3,50&chd=t:0.0,1.0,3.0,6.0,12.0,24.0|0.0,0.0,0.2,0.4,0.35,0


Cumulative Excretion in Urine (µmol)
Number Dose Multiple Dose Duration Time (hours) Polyphenol Source
Name as described in publication
0 6 12 24
1 1 capsule Single Dose 0 4 19 31
daidzein capsule
Chart?cht=lxy&chs=600x300&chf=bg,s,fafafa&chxt=x,x,y&chxr=0,0.0,24.240000000000002,2|2,0.0,31.31,2&chds=0.0,24.240000000000002,0.0,31.31&chxl=1:|time+after+ingestion+(hours)&chtt=cumulative+excretion+in+urine+(µmol)&chxp=1,50|3,50&chd=t:0.0,6.0,12.0,24.0|0.0,4.0,19.0,31